David A. Nielsen

8.3k total citations · 1 hit paper
118 papers, 6.4k citations indexed

About

David A. Nielsen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David A. Nielsen has authored 118 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cellular and Molecular Neuroscience, 45 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in David A. Nielsen's work include Neurotransmitter Receptor Influence on Behavior (47 papers), Cannabis and Cannabinoid Research (26 papers) and Substance Abuse Treatment and Outcomes (16 papers). David A. Nielsen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (47 papers), Cannabis and Cannabinoid Research (26 papers) and Substance Abuse Treatment and Outcomes (16 papers). David A. Nielsen collaborates with scholars based in United States, China and Sweden. David A. Nielsen's co-authors include Mary Jeanne Kreek, K. Steven LaForge, Eduardo R. Butelman, David J. Shapiro, D F Steiner, David Goldman, Ann Ho, Michael Welsh, Thomas R. Kosten and Vadim Yuferov and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

David A. Nielsen

115 papers receiving 6.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

2005 753 citations Mary Jeanne Kreek, David A. Nielsen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David A. Nielsen	2.4k	2.2k	829	814	700	118	6.4k
Robert H. Lipsky	2.6k 1.1×	2.5k 1.1×	806 1.0×	752 0.9×	709 1.0×	112	8.1k
Gary S. Wand	1.8k 0.7×	2.4k 1.1×	389 0.5×	814 1.0×	535 0.8×	178	8.8k
Bertram Müller‐Myhsok	2.0k 0.8×	1.0k 0.5×	1.7k 2.0×	799 1.0×	460 0.7×	197	8.7k
Yoshifumi Watanabe	2.3k 1.0×	2.1k 1.0×	663 0.8×	362 0.4×	387 0.6×	195	8.9k
Leonard H. van den Berg	3.3k 1.4×	2.7k 1.2×	587 0.7×	472 0.6×	545 0.8×	260	12.9k
Simon Scharpé	2.3k 1.0×	2.3k 1.0×	381 0.5×	371 0.5×	622 0.9×	190	11.7k
Manfred Uhr	1.7k 0.7×	1.1k 0.5×	531 0.6×	1.1k 1.3×	914 1.3×	199	10.2k
Synthia H. Mellon	3.3k 1.4×	2.3k 1.0×	2.2k 2.6×	718 0.9×	428 0.6×	157	12.6k
Günter Schumann	1.1k 0.5×	1.8k 0.8×	453 0.5×	899 1.1×	333 0.5×	159	6.4k
Torbjörn Bäckström	1.1k 0.5×	1.9k 0.9×	1.3k 1.6×	683 0.8×	744 1.1×	250	11.2k

Countries citing papers authored by David A. Nielsen

Since Specialization

Citations

This map shows the geographic impact of David A. Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Nielsen more than expected).

Fields of papers citing papers by David A. Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Nielsen. The network helps show where David A. Nielsen may publish in the future.

Co-authorship network of co-authors of David A. Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Nielsen. A scholar is included among the top collaborators of David A. Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Nielsen. David A. Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rufino, Katrina A., et al.. (2024). Val/Met BDNF as a genetic risk for a false sense of security in post-discharge suicide risk. Journal of Affective Disorders. 354. 98–103. 1 indexed citations

Wilkinson, Anna V., Baojiang Chen, Alan C. Swann, et al.. (2024). Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas. Nicotine & Tobacco Research. 27(1). 54–60.

Nielsen, David A., et al.. (2023). Promoter region variant C‐824T in the TH gene modulates the subjective effects of cocaine. American Journal on Addictions. 32(5). 506–509. 1 indexed citations

Oldham, John M., et al.. (2023). miR-124-3p target genes identify globus pallidus role in suicide ideation recovery in borderline personality disorder. SHILAP Revista de lepidopterología. 2(1). 8–8. 1 indexed citations

Đạt, Nguyễn Tiến, Savannah N. Gosnell, Michelle A. Patriquin, et al.. (2022). A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in Suicidality. SHILAP Revista de lepidopterología. 6. 2290705460–2290705460. 4 indexed citations

Graham, David P., Mark J. Harding, & David A. Nielsen. (2022). Pharmacogenetics of Addiction Therapy. Methods in molecular biology. 2547. 437–490. 3 indexed citations

Nielsen, David A., Huiqiong Deng, Michelle A. Patriquin, et al.. (2019). Association of TPH1 and serotonin transporter genotypes with treatment response for suicidal ideation: a preliminary study. European Archives of Psychiatry and Clinical Neuroscience. 270(5). 633–642. 12 indexed citations

Deng, Huiqiong, Christopher D. Verrico, Thomas R. Kosten, & David A. Nielsen. (2018). Psychosis and synthetic cannabinoids. Psychiatry Research. 268. 400–412. 49 indexed citations

Curtis, Kaylah N., Humsini Viswanath, Kenia M. Velasquez, et al.. (2017). Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant. American Journal on Addictions. 26(7). 751–759. 27 indexed citations

10.

Patriquin, Michelle A., Isabelle E. Bauer, Jair C. Soares, David P. Graham, & David A. Nielsen. (2015). Addiction pharmacogenetics. Psychiatric Genetics. 25(5). 181–193. 37 indexed citations

11.

Frazier, Thomas, Eric A. Youngstrom, Giovana Zunta‐Soares, et al.. (2014). Candidate gene associations with mood disorder, cognitive vulnerability, and fronto‐limbic volumes. Brain and Behavior. 4(3). 418–430. 23 indexed citations

12.

Anastasio, Noelle C., Scott D. Lane, Robert G. Fox, et al.. (2014). Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity. Translational Psychiatry. 4(3). e369–e369. 33 indexed citations

13.

Spellicy, Catherine J., Thomas R. Kosten, Sara Hamon, Mark J. Harding, & David A. Nielsen. (2013). The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency. Frontiers in Psychiatry. 3. 109–109. 12 indexed citations

14.

Nielsen, David A., Fei Ji, Vadim Yuferov, et al.. (2010). Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. Psychiatric Genetics. 20(5). 207–214. 48 indexed citations

15.

Levran, Orna, Douglas Londoño, David A. Nielsen, et al.. (2008). Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain & Behavior. 7(7). 720–729. 169 indexed citations

16.

Brand, Caroline, et al.. (2004). A transitional care service for elderly chronic disease patients at risk of readmission. Australian Health Review. 28(3). 275–284. 40 indexed citations

17.

Roy, Alec, Gunnar Rylander, Kaj Forslund, et al.. (2001). Excess Tryptophan Hydroxylase 17 779C Allele in Surviving Cotwins of Monozygotic Twin Suicide Victims. Neuropsychobiology. 43(4). 233–236. 41 indexed citations

18.

Rotondò, Antonio, Kornel E. Schuebel, Andrew W. Bergen, et al.. (1999). Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Molecular Psychiatry. 4(4). 360–368. 71 indexed citations

19.

Jönsson, Erik G., David Goldman, Gillian Spurlock, et al.. (1997). Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247(6). 297–302. 99 indexed citations

20.

Steiner, Donald F., Christoph Patzelt, Shu Jin Chan, et al.. (1980). Formation of biologically active peptides. Proceedings of the Royal Society of London. Series B, Biological sciences. 210(1178). 45–59. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact